MerrillJ. P.: Hypertensive Vascular Disease, in Principles of Internal Medicine 6th ed. by HarrisonT. R. (Eds.), McGraw-Hill Book Co., Inc.New York, 1970.
2.
BrustA. A., PereraG. A., and WilkinsR. W.: Report of Ad Hoc Subcommittee of the A.M.A. Committee on Research, J. Amer. Med. Assoc.166: 640–641 (Feb. 8) 1958.
3.
BrainerdH.et al.: Current Diagnosis & Treatment, Lange Medical Publications, Los Altos, Calif., 1970, page 177.
4.
EpsteinF. H.: Acute Renal Failure, in Principles of Internal Medicine 6th ed. by HarrisonT. R., (Eds.), McGraw-Hill Book Co., Inc., New York, 1970.
5.
GoldenA., & MaherJ. F.: The Kidney, The Williams and Wilkins Company, Baltimore, 1971.
6.
MilneM. D.: Renal Tubular Dysfunction, in Diseases of the Kidney 2nd ed. by StraussM. B., & WeltL. G., (Eds.), Vol. II, Little, Brown, and Company, Boston, 1971.
7.
EpsteinF.: Diseases of the Kidneys, in Principles of Internal Medicine 4th ed. by HarrisonT. R. (Eds.), McGraw-Hill Book Co., Inc., New York, 1962.
8.
PapperS., & VaamondeC. A.: Nephrosclerosis, in Diseases of the Kidney 2nd ed. by StraussM. B., & WeltL. G., (Eds.), Vol. II, Little, Brown, and Company, Boston. 1971.
9.
EpsteinF. H.: Vascular Diseases of the Kidney. Toxemia of Pregnancy, in Principles of Internal Medicine 6th ed., by HarrisonT. R. (Eds.), McGraw-Hill Book Company, Inc., New York, 1970.
10.
RavelR.: Clinical Laboratory Medicine, Year Book Medical Publishers, Inc., Chicago, 1969.
11.
GriffithJ. F., & AdamsR. D.: Headache, in Principles of Internal Medicine 6th ed. by HarrisonT. R., McGraw-Hill Book Company, Inc., New York1970.
12.
Classification of Headache, Committee on Classification of Headache, National Institute of Neurological Diseases and Blindness composed of Dr. A. P. Friedman, (Chairman), et al.: J. Amer. Med. Assoc.179: 717 (Mar. 3) 1962.
13.
MoertelC. G.: A Comparative Evaluation of Marketed Analgesic Drugs, N.E.J. Med.286: 15: 813 (April 13) 1972.
14.
BeaverW. T.: Mild Analgesics. A Review of Their Clinical Pharmacology, Amer. J. Med. Sci.251: 576–599, 1966.
BeaverW. T.: The Pharmacologic Basis for the Choice of an Analgesic, II. Mild Analgesics, Pharmacol. Physicians4: 12, 1970.
17.
LeonardsJ. R., and LevyG.: Reduction or Prevention of Aspirin-Induced Occult Gastrointestinal Blood Loss in Man, Clin. Pharmacol. Ther.10: 571–575, 1969.
18.
BattermanR. C.: Comparison of Buffered and Unbuffered Acetylsalicylic Acid, N.E.J. Med.258: 213, 1958.
19.
CronkG. A.: Laboratory and Clinical Studies with Buffered and Unbuffered Acetylsalicylic Acid, N.E.J. Med.258: 219, 1958.
20.
DeKornfeldT. J., LasagnaL., & FrazierT. M.: A Comparative Study of Five Proprietary Analgesic-Compounds, J. Amer. Med. Assoc.182: 1315–1318, 1962.
21.
LeonardsJ. R.: The Influence of Solubility on the Rate of Gastrointestinal Absorption of Aspirin, Clin. Pharmacol. Ther.4: 476–479, 1963.
22.
LimR. K. S.: Neuropharmacology of Pain and Analgesia, in Pharmacology of Pain, edited by LimR. K. S., ArmstrongD., and PardoE. G., from the Third International Pharmacological Meeting, Vol. 9 Pergamon Press, New York, 1968.
23.
The Medical Letter14: 9, (Issue 347) (Apr. 28) 1972, Page 32.
24.
CroftD. N., & WoodP. H. N.: Gastric Mucosa and Susceptibility to Occult Gastrointestinal Bleeding Caused by Aspirin, Brit. Med. J.1: 137–141, 1967.
25.
DavenportH. W.: Salicylate Damage to the Gastric Mucosal Barrier, N.E.J. Med.276: 1307–1312, 1967.
26.
RitchieJ. M.: Central Nervous System Stimulants, in The Pharmacological Basis of Therapeutics 4th ed., GoodmanL. S., & GilmanA. (Eds.) The MacMillan Company, New York, 1970.
27.
ReynoldsT. G., & EdmondsonH. A.: Chronic Renal Disease and Heavy Use of Analgesics, J. Amer. Assoc.184: 435–444, 1963.
28.
FellnerS. K., and TuttleE. P.: The Clinical Syndrome of Analgesic Abuse, Arch. Intern. Med.124: 379, 1969.
29.
LasagnaL.: The Clinical Pharmacology of Analgesics and Analgesic Antagonists, in Pharmacology of Pain, LimR. K. S., ArmstrongD., & PardoE. G., Eds., Third International Pharmacological Meeting, Vol. 9. Pergamon Press, New York, 1968.
30.
MeylerL. (ed.): Side Effects of Drugs, Vol. VExcerpta Medica Foundation, New York, 1966.
31.
Horwitz, Drug Therapy of Hypertension, Med. Ann. District Columbia38: 1 (Jan.) 1969.
32.
PageH. (Ed.),: Symposium on Hypertension, Modern Med.40: 10 (Mar. 20) 1972.
33.
Lund-JohansenP.: Hemodynamic Changes in Long-Term Diuretic Therapy of Essential Hypertension, Acta. Med. Scand.187: 509–518, 1970.
34.
BeeversD. G.: Hamilton, M., & Harpur, J. E.: The Long Term Treatment of Hypertension with Thiazide Diuretics, Postgrad. Med. J.47: 639–643 (Oct.) 1971.
35.
MarondeR. F., MilgromM., and DickeyJ. M.: Potassium Loss with Thiazide Therapy, Amer. Heart J.78: 16–21 (July) 1969.
36.
FichmanM. P., VorherrH., KleemanC. R., and TelferNancy: Diuretic-Induced Hyponatremia, Ann. Intern. Med.75: 853–863 (Dec.) 1971.
37.
EngelmanK., & BraunwaldE.: Elevation of Arterial Pressure, in Principles of Internal Medicine 6th ed., by HarrisonT. R. (Eds.), McGraw-Hill Book Company, Inc., New York, 1970.
38.
ShapiroA. P. (ed.): Symposium on Treatment of Hypertension, Modern Treatment3: 13 (Jan.) 1966.
39.
BrestA. N.: Mechanisms of Antihypertensive Drug Therapy, J. Amer. Med. Assoc.211: 480 (Jan. 19) 1970.
40.
VolleR. L., & KoelleG. B.: Ganglionic Stimulating and Blocking Agents, in The Pharmacological Basis of Therapeutics 4th ed. GoodmanL. S., & GilmanA. (Eds.), The MacMillan Company, New York, 1970.
41.
Personal Communication, LeedsMorton W., Ph.D., Manager, Clinical Development, CIBA Pharmaceutical Company.
42.
Milgrom, Mildred: Ass't. Prof. of Medicine, Section of Clinical Pharmacology, LAC/USC Med. Center and School of Medicine, Univ. of So. Calif.
43.
WeltL. G.: Oliguria, Polyuria, and Nocturia, in Principles of Internal Medicine 6th ed. by HarrisonT. R. (Eds.), McGraw-Hill Book Company, Inc., 1970.
44.
PapperS.: Clinical Nephrology, Little, Brown, and Company, Boston, 1971.
45.
HoffmanW. S.: The Biochemistry of Clinical Medicine, 4th ed., Year Book Medical Publishers Inc., Chicago, 1970.
46.
KassierJ. P.: Current Concepts: Clinical Evaluation of Kidney Function - Glomerular Function, N.E.J. Med.285: 385 (Aug. 12) 1971.
47.
BerlinerR. W.: Outline of Renal Physiology, in Diseases of the Kidney 2nd ed., by StraussM. B., and WeltL. G. (Eds.), Vol. I, Little, Brown and Company, Boston, 1971.
48.
RelmanA. S., & LevinskyN. G.: Clinical Examination of Renal Function, in Diseases of the Kidney 2nd ed. by StraussM. B., & WeltL. G. (Eds.), Vol. I, Little, Brown and Company, Boston, 1971.
49.
KassierJ. P.: Current Concepts: Clinical Evaluation of Kidney Function - Tubular Function, N.E.J. Med.285: 499 (Aug. 26) 1971.
50.
WellsB. B., & HalstedJames A.: Clinical Pathology 4th ed., W. B. Saunders Company, Philadelphia, 1967.
51.
GuytonA. C.: Textbook of Medical Physiology 4th ed., W. B. Saunders Company, Philadelphia, 1971.
52.
PittsR. F.: Physiology of the Kidney and Body Fluids 2nd ed., Year Book Medical Publishers Inc., Chicago, 1968.
53.
LeaderA. J., & CarltonC. E.: Urologic Diagnosis and the Urologic Examination, in Urology 3rd ed., by CampbellM. F., & HarrisonJ. H. (Eds.), Vol. I., W. B. Saunders Company, Philadelphia, 1970.
54.
SmithD. R.: General Urology 7th ed., Lange Medical Publications, Los Altos, Calif.1972.
LippmanR. W.: Urine and the Urinary Sediment, 2nd ed., Charles C Thomas, Publisher, Springfield, Ill., 1957.
57.
EpsteinF. H., & MerrillJ. P.: Chronic Renal Failure, in Principles of Internal Medicine 6th ed., by HarrisonT. R. (Eds.), McGraw-Hill Book Co., Inc., New York, 1970.
CapelliJ. P., EssonL. G., and ErsleuA. J.: Malignant Hypertension and Red Cell Fragmentation Syndrome, Ann. Intern. Med.64: 128–136, 1966.
60.
BullB. S.: Microangiopathic Hemolytic Anemia: Mechanisms of Red Cell Fragmentation, Brit. J. Haematol.14: 643–652, 1968.
61.
DesforgesJ. D., & DawsonJ. P.: The Anemia of Renal Failure, Arch. Intern. Med.101: 326–332, 1958.
62.
LageJ. B., LangeR. D., & MooreC. V.: Characterization of the Anemia Associated with Renal Insufficiency, Amer. J. Med.24: 4–18, 1958.
63.
KayeM.: The Anemia Associated with Renal Disease, J. Lab. Clin Med.52: 83–100, 1958.
64.
StewartH. H.: Haemolytic Anaemia in Acute and Chronic Renal Failure, Quart. J. Med.36: 85–105, 1967.
65.
GutmanA. Eds.: Gout — A Clinical ComprehensiveMEDCOM, Inc., for Burroughs Wellcome Co., 1971.
66.
PageL. B., & SiddJ. J.: Medical Management of Primary Hypertension, Part II:, N.E.J. Med.287: 1018–1023 (Nov. 16) 1972.
67.
DustanHarriet P., TaraziR. C., & BraveE. L.: Physiologic Characteristics of Hypertension, Amer. J. Med.52: 610–622 (May) 1972.
68.
GitelmanH. J.: Uremic Toxins and Mineral Metabolism, Arch. Intern. Med.126: 793–800 (Nov.) 1970.
69.
D'ArcyP. F., & GriffenJ. P.: Iatrogenic Disease, Oxford Univ. Press, New York, 1972, pg. 106.
70.
SeitzH., & JaworskiZ. F.: Effect of Hydrochlorothiazide on Serum and Urinary Citrate, Canad. Med. Assoc. J.90: 414–420, 1964.
71.
ReubiF. C., & ButikoferE.: Haemodynamics of Long-Term Antihypertensive Treatment, in Circulatory Drugs, BertelliA. (Ed.), John Wiley & Sons, Inc., New York, 1969, pp. 190–194.
72.
GiffordR. W.Jr., and HumphreyD. C.: Drug Management of the Ambulatory Patient with Hypertension, in Symposium on Cardiovascular Drug Therapy, BrestA. N., and MoyerJ. H. (Eds.), Grune & Stratton, Inc., New York, 1965, pp. 52–65.
73.
Nies, & MelmonK.: Recent Concepts in the Clinical Pharmacology of Antihypertensive Drugs, Calif. Med.106: 388 (May) 1967.
74.
AokiV. S., & WilsonW. R.: Hydralazine and Methyldopa in Thiazide-Treated Hypertensive Patients, Amer. Heart J.79: 798–804 (June) 1970.
75.
Medical Staff Conference, Dept. of Med., Univ. Calif. San Francisco: Current Concepts in the Treatment of Hypertension, Calif. Med.115: 58–67 (July) 1971.
76.
JohnsonL. C., SantosD. E., & GanttC.: The Antihypertensive Properties of Furosemide On Chronic Oral Administration, J. Clin. Pharmacol.121–125 (Mar.-Apr.) 1970.
77.
AndersonJ.: A Comparison of the Effects of Hydrochlorothiazide and of Furosemide in the Treatment of Antihypertensive Patients, Quart. J. Med.160: 541–560 (Oct.) 1971.
78.
MuthR.: Diuretic Properties of Furosemide in Renal Disease, Ann. Intern. Med.69: 249, 1968.
79.
BermanL. B., & EbrahimiA.: Experiences with Furosemide in Renal Disease, Proc. Soc. Exp. Biol. Med.118: 333, 1965.
80.
SmithJ. W., SeidlL. G., & CluffL. E.: Studies on the Epidemiobgy of Adverse Drug Reactions, Ann. Intern. Med.65: 629 (Oct.) 1966.
81.
McIsaacW. M., & KandaM.: The Metabolism of 1-Hydrazinophthalazine, J. Pharmacol. Exp. Ther.143: 7–13. 1964.
82.
ReidenbergM. M., KostenbauderH., & AdamsW.: Rate of Drug Metabolism in Obese Volunteers Before and During Starvation and in Azotemic Patients, Metabolism18: 209–213, 1969.
83.
PageL. B., & SiddJ. J.: Medical Management of Primary Hypertension, N.E.J. Med.287: Part I, 960 (Nov. 9) 1972; Part II., 1018 (Nov. 16) 1972; Part III., 1074 (Nov. 23) 1972.
84.
PageH. (Ed.): Symposium on Hypertension, Modern Med.40: 8–60 (Mar. 20) 1972.
85.
MoyerJ. H.III: Optimum Therapy for Essential Hypertension, Family Practice5: 102 (June) 1972.
86.
BourneH. R., & MelmonK. L.: Guides to the Pharmacologic Management of Essential Hypertension, Pharmacol. Physicians5: (Apr.) 1971.
87.
FuiszR. E. (ed.): A Mosaic in Medicine - Hypertension, MEDCOM, INC., for Merck, Sharp and Dohme, 1971.
88.
KaufmanJ. J. (Ed.),: UCLA Conference: Hypertension - Primary and Secondary, Ann. Intern. Med.75: 761 (Nov.) 1971.
89.
KaufmanJ. J., MaxwellM. H., CravenJ. D., & OkumR.: Hypertension-Primary and Secondary, Ann. Intern. Med.75: 767 (Nov.) 1971.
90.
SurindarB., & FrohlichE. D.: The Hypertensive Evaluation, Family Physician5: 83 (Feb.) 1972.
91.
FraleyE. E., & FeldmanB. H.: Current Concepts: Renal Hypertension, N.E.J. Med.287: 550 (Sept. 14) 1972.
92.
Symposium on Hypertension: Mechanisms and Management, Amer. J. Med.52: 565–678 (May) 1972.